Alethea Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-750,465
| Closed | -$720K | – | 70 |
|
|
2023
Q2 | $720K | Sell |
750,465
-37,508
| -5% | -$37.1K | 0.77% | 12 |
|
|
2023
Q1 | $591K | Hold |
787,973
| – | – | 0.62% | 18 |
|
|
2022
Q4 | $290K | Hold |
787,973
| – | – | 0.28% | 29 |
|
|
2022
Q3 | $339K | Hold |
787,973
| – | – | 0.43% | 23 |
|
|
2022
Q2 | $615K | Sell |
787,973
-389,142
| -33% | -$343K | 0.77% | 11 |
|
|
2022
Q1 | $1.52M | Hold |
1,177,115
| – | – | 1.37% | 7 |
|
|
2021
Q4 | $1.5M | Sell |
1,177,115
-479,700
| -29% | -$858K | 1.27% | 6 |
|
|
2021
Q3 | $3.61M | Buy |
1,656,815
+7,500
| +0.5% | +$20.5K | 3.18% | 4 |
|
|
2021
Q2 | $6.18M | Buy |
1,649,315
+49,866
| +3% | +$173K | 3.89% | 4 |
|
|
2021
Q1 | $5.21M | Buy |
1,599,449
+59,500
| +4% | +$213K | 3.18% | 4 |
|
|
2020
Q4 | $5.25M | Buy |
1,539,949
+62,737
| +4% | +$258K | 2.63% | 5 |
|
|
2020
Q3 | $6.03M | Buy |
1,477,212
+342,941
| +30% | +$1.3M | 4.08% | 3 |
|
|
2020
Q2 | $3.83M | Buy |
1,134,271
+450,082
| +66% | +$1.31M | 2.24% | 3 |
|
|
2020
Q1 | $1.59M | Buy |
+684,189
| New | +$1.87M | 1.03% | 7 |
|
|
2017
Q1 | – | Sell |
-24,577
| Closed | -$109K | – | 107 |
|
|
2016
Q4 | $109K | Hold |
24,577
| – | – | 0.14% | 70 |
|
|
2016
Q3 | $115K | Buy |
+24,577
| New | +$146K | 0.16% | 60 |
|
Alethea Capital Management's SPPI Position: Q3 2023 in Review
Alethea Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 750,465 shares — an estimated $720K sold.
Alethea Capital Management first reported a position in SPPI in Q3 2016 and held it in 16 quarters. The position peaked at $6.18M in Q2 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Alethea Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Alethea Capital Management sold 750,465 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $720K.
- Alethea Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2016 and held it in 16 quarters.
- Alethea Capital Management's Spectrum Pharmaceuticals Inc position peaked at $6.18M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Alethea Capital Management's 13F filing for Q3 2023, filed 15 Nov 2023.